XESX:LSE:LSE-Xtrackers Euro Stoxx 50 UCITS ETF 1D (GBX)

ETF | Others |

Last Closing

USD 4153

Change

+86.00 (+2.11)%

Market Cap

N/A

Volume

4.82K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-14 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XNID:LSE Xtrackers Nifty 50 Swap UCITS ..

+0.38 (+0.14%)

USD 292,109.69B
0R1O:LSE Amazon.com Inc.

N/A

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

+0.41 (+0.28%)

USD 618.20B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

+0.05 (+0.39%)

USD 584.80B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

+0.05 (+0.30%)

USD 583.82B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

-0.30 (-0.48%)

USD 266.08B
0QZO:LSE 0QZO

+8.80 (+8.82%)

USD 258.54B
PRJU:LSE Amundi Index Solutions - Amund..

+0.08 (+0.26%)

USD 218.91B
0QZ3:LSE Qualcomm Inc.

+2.23 (+1.38%)

USD 202.26B

ETFs Containing XESX:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 1.61% 32% F 42% F
Dividend Return -0.07% 74% C 9% A-
Total Return 1.54% 33% F 41% F
Trailing 12 Months  
Capital Gain 6.45% 36% F 43% F
Dividend Return -0.07% 73% C 9% A-
Total Return 6.37% 37% F 43% F
Trailing 5 Years  
Capital Gain 23.28% 49% F 57% F
Dividend Return -0.03% 88% B+ 83% B
Total Return 23.25% 50% F 57% F
Average Annual (5 Year Horizon)  
Capital Gain 9.48% 62% D 66% D+
Dividend Return 9.49% 62% D 66% D+
Total Return 0.02% 25% F 22% F
Risk Return Profile  
Volatility (Standard Deviation) 13.73% 52% F 69% C-
Risk Adjusted Return 69.14% 73% C 83% B
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.